Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.
Earnings for Shin Poong Pharm.Co.,Ltd. (019170.KS)
Earnings in 2023 (TTM): $-38,209,857
According to Shin Poong Pharm.Co.,Ltd.'s latest financial reports the company's current earnings (TTM) are $-38,209,857. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Shin Poong Pharm.Co.,Ltd.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-38,209,857 | $-40,986,549 |
| 2022 | $-24,868,130 | $-25,245,133 |
| 2021 | $-6,424,563 | $-8,240,876 |
| 2020 | $5.96 M | $3.58 M |
| 2019 | $5.09 M | $3.81 M |
| 2018 | $3.71 M | $2 M |
| 2017 | $1.22 M | $646.98 K |
| 2016 | $-2,647,693 | $-13,292,707 |
| 2015 | $1.55 M | $1.06 M |
| 2014 | $9.66 M | $2.39 M |
| 2013 | $14.07 M | $3.89 M |
| 2012 | $12.91 M | $10.28 M |
| 2011 | $22.52 M | $17.78 M |
| 2010 | $27.41 M | $15.54 M |
| 2009 | $22.03 M | $15.05 M |
| 2008 | $14.61 M | $8.62 M |
| 2007 | $11.05 M | $6.32 M |